Please provide your email address to receive an email when new articles are posted on . Patients dosed with certolizumab pegol for moderate to severe plaque psoriasis achieved and maintained absolute ...
Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis who received abatacept or certolizumab pegol were more likely to achieve ...
UCB's CIMZIA® (certolizumab pegol) approved by the U.S. FDA for adult patients suffering from moderate to severe rheumatoid arthritis Available this week, Cimzia® (certolizumab pegol), the only ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
The range of recombinant monoclonal anti-idiotypic antibodies comprises three antibodies that are highly specific for the monoclonal antibody Fab fragment certolizumab pegol (Cimzia) and inhibit the ...
Hosted on MSN
Lupin, Zentiva Sign Global Pact For Certolizumab Pegol, Biosimilar To Be Commercialised Across Key Markets
New Delhi: Pharma major Lupin Ltd on Wednesday said it has inked a license and supply pact for commercialisation of its biosimilar 'Certolizumab Pegol' across multiple global markets with the Zentiva ...
Lupin and Zentiva, a pan-European pharmaceutical company, have entered into a license and supply agreement for commercialization of Lupin’s biosimilar Certolizumab Pegol, across multiple markets ...
HERCULES, Calif. – 5 May 2020 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of a range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback